Abstract
Cervical cancer (CC) is women’s fourth most common cancer worldwide. A worrying increase in CC rates in Hispanics suggests that besides Human Papillomaviruses infections, there may be other biological causes promoting the disease. We hypothesized that the cervical microbiome and the epithelial microenvironment favoring inflammation is conducive to disease progression. There is a lack of studies examining the part played by microbial populations in the development of precancerous lesions into cancer in Hispanic women. We aimed to investigate the relationship between the cervicovaginal microbiome and inflammation in Hispanic women living in PR while considering cervical neoplasia and HPV infection. Cervical samples collected from 91 participants coming to clinics in San Juan, underwent 16S rRNA genes (V4 region) profiling, and cytokines were measured using Luminex MAGPIX technology. Cytokines were grouped as inflammatory (IL-1β, TNFα, IFNγ, IL-6), anti-inflammatory (IL-4, IL-10, TGFβ1), and traffic-associated (IL-8, MIP1a, MCP1, IP10). They were related to microbes via an inflammation scoring index based on the quartile and tercile distribution of the cytokine’s concentration. We found significant differences in the diversity and composition of the microbiota according to HPV risk, cervical disease, and cytokine abundance. The most dominant community state type (CST) was CST IV with ∼ 90% dominance in participants with high-grade squamous intraepithelial lesions and high-risk HPV. The increasing concentration of pro-inflammatory cytokines was associated with a decrease in L. crispatus. In contrast, dysbiosis-associated bacteria such as Gardnerella, Prevotella, Atopobium concomitantly increased with pro-inflammatory cytokines. Our study highlights that the cervical microbiota of Hispanics living in PR is characteristically diverse, regardless of HPV status and that dysbiosis associated with a decrease in Lactobacillus marks inflammatory processes. Therefore, the joint host-microbe interaction analyses via cytokine signaling and microbiota in precancerous lesions is confirmed to have great translational potential.
Competing Interest Statement
The authors have declared that no competing interests exist
Funding Statement
FGV Puerto Rico Science and Technology and Research Trust award, #2020-00112 FGV Center for Collaborative Research in Minority Health and Health Disparities (RCMI), 2U54MD007600 FGV The Hispanic Alliance for Clinical and Translational Research (Alliance), U54GM133807 FGV NIGMS RISE Program at the UPR Medical Sciences Campus, R25GM061838 FGV Hispanics-In-Research Capability: SoHP & SoM Partnership (HiREC), S21MD001830 FGV The Puerto Rico IDeA Networks of Biomedical Research Excellence Advancing Competitive Biomedical Research in Puerto Rico, 5P20GM103475-20
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UPR-Medical Sciences Campus IRB (Protocol ref. 1050114), San Juan City Hospital UPR-Medical Sciences Campus biosafety approval protocol # 94620
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The 16S-rRNA reads and corresponding sample metadata was deposited in QIITA study ID 12871 and the raw sequences are available in the European Nucleotide Archive ENA Project under accession number EBI: ERP136546. https://www.ebi.ac.uk/ena/browser/view/PRJEB51893